Muthanna Medical Journal

Dyslipidemia is a well-documented and a common finding in patients with CRF and its
prevalence is higher than in general population. Lipid profile has been studied in 50 patients
with CRF excluding patients on hemodialysis or renal transplantation, and in 48 normal
subjects of matched age and sex as a control. Also, the proteinuria in GUE was assessed and a
history of hypertension was evaluated in patients’ group. Dyslipidemia was found in 80% of
patients with CRF who have significantly higher s. triglyceride and VLDL-C and lower HDL
C levels than control (P value <0.0005 for triglyceride and HDL-C and < 0.005 for VLDL-C).
The commonest abnormality was hypertiglyceridemia (56%). The frequencies of other lipid
abnormalities were as follows: low HDL-C level (52%), high LDL-C level (32%), and
hypercholesterolemia (22%). Among patients with abnormal lipid profile, 70% of them have
hypertension, and the same percentage have proteinuria. The dyslipidemia distributed evenly
along the course of renal failure, so it can occur in the early course of CRF as well as in the
late one. In conclusion, dyslipidemia is present in a significant number of patients with CRF
regardless of the duration of renal failure; also, it is significantly associated with hypertension
and/or proteinuria.

We conducted a scientific study for one year at the Specialized Center for Diabetes (Iraq
Samawa) on the rate of increase of white cataract (eye water). Patients were 280 diabetic / type
II of aged ≥ 40 years with reduce the development of disease and collected randomly, included
women and men. The files of patients were reviewed and the nature of the process the disease
of high risk of obesity, high blood pressure, heart disease, high urea, creatinine, and COPD,
were involved in this scientific study for a full year at the specialized center for diabetes (Iraq
samawa). Patients were divided to four groups (4 codes); the first is the patient pre - diabetes
(30) patient and the second were diabetic (130) patient and the third chronic diabetes (98)
patient and the fourth (22) patient under control there is no diabetes. Work was accomplished
by the help of the ophthalmologist in diagnosis, transfer and follow-up before injury cataract
and after injury cataract and necessary surgery for the two patients We have the main goal of
preparing the patient for follow-up and medical treatment by controlling blood sugar and the
various risk factors that threaten the life of the patient and during the work). The medications;
Metaformin, Daonil, Amyral, Novenorm, Statin, Aspirin, Saxaglaptin were used in this
study. All precautions to maintain the health of the patients and improve the living, also
reducing the rate of diabetes and cataracts eye clearly and according to the census. The age
after 65 years were the most vulnerable to cataracts and females (9 -16%) are more likely
than men (6% - 11%) to have cataracts, as conclusion; the irregular diabetes is a risk factor
of cataracts with the cooperation of other factors like age.

Thalassemia is an autosomal recessive blood disorder which has a life-long implication in both patients and their families. This study was performed at Al-Diwaniya maternity and children teaching hospital from the 1st of October 2016 to the 1st of January 2017. The total number of patients involved in our study were one-hundred three, all of them were diagnosed with ß – thalassemia major, were subjected to frequent blood transfusion and were on chelating agent. Both patients groups were evaluated with full history (age, gender, time of diagnosis, the rate of transfusion per year, the type and dose of the chelating agent), and were examined for their weight, height and BMI, serum ferritin was also performed for all of them. There was a significant difference in mean age and height of patients on desferal and those on exjade. The rate of transfusion was significantly greater in the group of patients treated with desferal. Serum ferritin was significantly higher in patients treated with desferal than patients treated with exjade. There was a significant correlation between gender of patients and serum ferritin in the group of patients treated with desferal, also there was a significant negative correlation between the dose of the drug and serum ferritin in those treated with exjade.